MetaCap

AnaptysBio (ANAB) News

NASDAQ: ANABHealth CareBiotechnology: Pharmaceutical PreparationsUSD

46.63-0.77 (-1.62%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ANAB news summary

We found 12 recent headlines mentioning AnaptysBio (ANAB): 1 in the past week and 6 in the past 30 days, most often from Nasdaq, Seeking Alpha, GlobeNewswire. For price context, ANAB is down 1.62% at $46.63. The most recent story, "3 Stocks With Superb Earnings Acceleration to Buy Before 2027", was published by Nasdaq on Nov 19, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest AnaptysBio headlines

Stocks mentioned alongside ANAB

Compare ANAB